Regeneron Pharmaceuticals
REGN
#288
Rank
NZ$131.79 B
Marketcap
NZ$1,243
Share price
-0.61%
Change (1 day)
-6.28%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Cash on Hand

Cash on Hand as of September 2025 : NZ$14.61 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company has NZ$14.61 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regeneron Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$15.98 B-6.81%
2023-12-31NZ$17.14 B40.63%
2022-12-31NZ$12.19 B46.27%
2021-12-31NZ$8.33 B67.71%
2020-12-31NZ$4.97 B4.16%
2019-12-31NZ$4.77 B13.93%
2018-12-31NZ$4.18 B111.07%
2017-12-31NZ$1.98 B32.35%
2016-12-31NZ$1.49 B-1.81%
2015-12-31NZ$1.52 B32.88%
2014-12-31NZ$1.14 B36.09%
2013-12-31NZ$0.84 B125.49%
2012-12-31NZ$0.37 B-44.53%
2011-12-31NZ$0.67 B108.88%
2010-12-31NZ$0.32 B-31.22%
2009-12-31NZ$0.46 B-42.56%
2008-12-31NZ$0.81 B-18.24%
2007-12-31NZ$1.00 B53.49%
2006-12-31NZ$0.65 B49.25%
2005-12-31NZ$0.43 B5.3%
2004-12-31NZ$0.41 B-8.21%
2003-12-31NZ$0.45 B-10.5%
2002-12-31NZ$0.50 B-45.55%
2001-12-31NZ$0.92 B249.41%
2000-12-31NZ$0.26 B109.51%
1999-12-31NZ$0.12 B237.16%
1998-12-31NZ$37.57 M-24.56%
1997-12-31NZ$49.8 M1.99%
1996-12-31NZ$48.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
NZ$16.34 B 11.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$4.71 B-67.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$6.85 B-53.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$32.13 B 119.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.88 B 15.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$18.09 B 23.78%๐Ÿ‡ซ๐Ÿ‡ท France